(Q45004033)

8 December 2017

Exercise capacity affects quality of life in patients with pulmonary hypertension (English)

1 reference

8 December 2017

1 reference

Michael Halank

1

1 reference

8 December 2017

Franziska Einsle

2

1 reference

8 December 2017

Stephanie Lehman

3

1 reference

8 December 2017

Hinrich Bremer

4

1 reference

8 December 2017

Ralf Ewert

5

1 reference

8 December 2017

Heinrike Wilkens

6

1 reference

8 December 2017

F Joachim Meyer

7

1 reference

8 December 2017

Ekkehard Grünig

8

1 reference

8 December 2017

Hans-Jürgen Seyfarth

9

1 reference

8 December 2017

Martin Kolditz

10

1 reference

8 December 2017

Gesine Wieder

11

1 reference

8 December 2017

Gert Höffken

12

1 reference

8 December 2017

Volker Köllner

13

1 reference

8 December 2017

language of work or name

1 reference

17 May 2013

1 reference

8 December 2017

1 reference

8 December 2017

191

1 reference

8 December 2017

4

1 reference

8 December 2017

337-343

1 reference

https://scigraph.springernature.com/pub.10.1007/s00408-013-9472-6

8 December 2017

0 references

cites work

Updated clinical classification of pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Guidelines for the diagnosis and treatment of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Measurement of quality of life in pulmonary hypertension and its significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Safety and efficacy of exercise training in various forms of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Bosentan therapy in patients with pulmonary arterial hypertension: the relationship between improvements in 6 minute walk distance and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Comparison and validation of three measures of quality of life in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Anxiety and depression in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Haemodynamic evaluation of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Burden of pulmonary arterial hypertension in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Cognitive behavioural intervention for adults with anxiety complications of asthma: prospective randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Psychoeducational treatment and prevention of depression: The “coping with depression” course thirty years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-013-9472-6

Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension

21 January 2018

1 reference

12 December 2020

Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension

1 reference

12 December 2020

The effectiveness of a minimal psychological intervention on self-management beliefs and behaviors in depressed chronically ill elderly persons: a randomized trial

1 reference

12 December 2020

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

12 December 2020

[Anxiety and depression in the general population: normal values in the Hospital Anxiety and Depression Scale]

1 reference

12 December 2020

Depressive symptoms in relation to physical functioning in pulmonary hypertension

1 reference

12 December 2020

Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension

1 reference

12 December 2020

10.1007/S00408-013-9472-6

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

0 references

1 reference